In the present study we demonstrate the existence of a new regulatory axis through which FHC, regardless of its redox-related activity, enhances p53 expression by down-regulation of miR-125b steady-state amounts in A549, H460, SW1573, and LXF-289 NSCLC cells lines. Here, TP53 is linked to non-small cell lung carcinoma.